13-015 · EVIDENCE B · SOURCE-SENSITIVE

Sudden widespread rash, difficulty breathing, or dizziness — treat as anaphylactic shock; call 120 immediately and explain the situation clearly.

突然全身起疹、喘不上气或者发晕,按过敏性休克处理,立刻叫 120 并说清楚

Source cost

No cost involved. However, people with known severe allergies must purchase epinephrine auto-injectors themselves; these are prescription-only medications.

Source return

If someone suddenly develops a full-body rash along with trouble breathing or dizziness, treat it as anaphylactic shock. Call 120 right away and clearly state “suspected anaphylactic shock” so emergency responders can bring epinephrine with them. Epinephrine is the first-line treatment; antihistamines and steroids act too slowly to be effective in such cases. Individuals who have experienced this before should consult a doctor for an epinephrine auto-injector and learn how to administer it to the outer midsection of the thigh — this can be done even through clothing.

Evidence grade

B

THE LOW-ROI DETOURSatire, not advice

Move “Sudden widespread rash, difficulty breathing, or dizziness — treat as anaphylactic shock; call 120 immediately and explain the situation clearly.” to Future Me's calendar

The excuse

Future Me has a clearer calendar, more patience, and apparently the same responsibilities.

What feels good now

Today I keep a few minutes and avoid interrupting my default routine.

What the source says

The source summarizes the return this way: “If someone suddenly develops a full-body rash along with trouble breathing or dizziness, treat it as anaphylactic shock. Call 120 right away and clearly state “suspected anaphylactic shock” so emergency responders can bring epinephrine with them. Epinephrine is the first-line treatment; antihistamines and steroids act too slowly to be effective in such cases. Individuals who have experienced this before should consult a doctor for an epinephrine auto-injector and learn how to administer it to the outer midsection of the thigh — this can be done even through clothing.” Evidence grade B. The original states the population, caveats, and sources; this is not a personal forecast.

THE ENGLISH EDITION

Original recommendation and evidence

Source commit a994b6a0c905

15. Sudden widespread rash, difficulty breathing, or dizziness — treat as anaphylactic shock; call 120 immediately and explain the situation clearly.

Cost: No cost involved. However, people with known severe allergies must purchase epinephrine auto-injectors themselves; these are prescription-only medications.

In plain terms: If someone suddenly develops a full-body rash along with trouble breathing or dizziness, treat it as anaphylactic shock. Call 120 right away and clearly state “suspected anaphylactic shock” so emergency responders can bring epinephrine with them. Epinephrine is the first-line treatment; antihistamines and steroids act too slowly to be effective in such cases. Individuals who have experienced this before should consult a doctor for an epinephrine auto-injector and learn how to administer it to the outer midsection of the thigh — this can be done even through clothing.

Benefit: Epinephrine is the recommended first-line treatment for all grades of anaphylactic shock (Grade 2 and above); clinical guidelines strongly endorse its use. Antihistamines and steroids are much slower-acting and cannot replace epinephrine in emergency situations.

Evidence grade: B (guidelines strongly recommend it, though the underlying evidence base is relatively weak).

Sources: et al. (2022). Clinical Practice Guidelines for Anaphylactic Shock Emergency Care (2020). Frontiers in Pharmacology: "Epinephrine is the first-line medicine in GRADE II to IV anaphylaxis" "Intramuscular epinephrine should be injected in the mid-anterolateral thigh", upper limit of intramuscular injection in adults: 0.5 mg, under 14 years of age: 0.3 mg, repeat every 5–15 minutes if no response. <https://doi.org/10.3389/fphar.2022.845689>; Muraro A, et al. (2022). EAACI guidelines: Anaphylaxis (2021 update). Allergy. <https://doi.org/10.1111/all.15032>

Notes: The EAACI allergy guidelines themselves note that “most evidence in this field remains at a low level.” They still classify epinephrine as a strongly recommended treatment because its benefits far outweigh the risks, rather than because of large-scale clinical trials. In China, epinephrine is a prescription medication and is not readily available to the general public. The best immediate action is to call 120 and clearly describe “suspected anaphylactic shock” so emergency teams can bring epinephrine along. Those with a history of severe allergic reactions should consult a doctor for an epinephrine auto-injector and learn how to inject it into the outer midsection of the thigh — this can be done through clothing as well.

Read the complete Chinese source and notes

15. 突然全身起疹、喘不上气或者发晕,按过敏性休克处理,立刻叫 120 并说清楚

成本: 不花钱。已知有严重过敏的人自备肾上腺素笔要花钱,而且它是处方药。

说人话: 突然全身起疹,再加上喘不上气或者发晕,就按过敏性休克办。立刻打 120,直接说「怀疑过敏性休克」,让急救带着肾上腺素来。抗过敏药和激素起效慢,替不了肾上腺素。有过一次的人找医生开自动注射笔,打大腿中外侧,隔着裤子也能打。

收益: 肾上腺素是二级及以上过敏性休克首选的药(一线药),指南把它列为强推荐。抗过敏药和激素起效慢,顶不了它的位置

证据等级: B(指南强推荐,但底层证据等级低)

来源: 中国医药教育协会等 (2022). 过敏性休克急救临床实践指南(2020). Frontiers in Pharmacology:「Epinephrine is the first-line medicine in GRADE II to IV anaphylaxis」「Intramuscular epinephrine should be injected in the mid-anterolateral thigh」,成人肌注上限 0.5 mg、14 岁以下 0.3 mg,无反应可每 5–15 分钟重复一次. <https://doi.org/10.3389/fphar.2022.845689>;Muraro A, et al. (2022). EAACI guidelines: Anaphylaxis (2021 update). Allergy. <https://doi.org/10.1111/all.15032>

备注: 这份过敏指南(EAACI)自己写明,这个领域「证据大多停留在很低的等级」。它列为强推荐,是因为好处远大于风险,不是因为有大型试验。肾上腺素在国内是处方药,普通人手上通常没有。能做的是叫 120,并说「怀疑过敏性休克」,让急救带着药来。有过一次严重过敏的,找医生开自动注射笔,学会打大腿中外侧(外侧偏前),隔着裤子也能打。

Author's scope notes: 这份过敏指南(EAACI)自己写明,这个领域「证据大多停留在很低的等级」。它列为强推荐,是因为好处远大于风险,不是因为有大型试验。肾上腺素在国内是处方药,普通人手上通常没有。能做的是叫 120,并说「怀疑过敏性休克」,让急救带着药来。有过一次严重过敏的,找医生开自动注射笔,学会打大腿中外侧(外侧偏前),隔着裤子也能打。

YOUR PRIVATE LIST

Choose what to do with this idea

Original content by eternity4719 under CC BY 4.0. English translation is credited in the source notes. HowToLiveWorse adds a clearly labeled satirical response.

Full source and adaptation notes